This trial is completed!
Search for a recruiting clinical trial for your condition
You can access this
clinical trial
if you have
Idiopathic Hypogonadotropic Hypogonadism
and you are a man who is
between 18 and 30
years old
Phase
4
The primary goal of this phase is to monitor the long-term effects.
The treatment is already on the market.
Show me locations

The purpose

The aim of the present study was to demonstrate the influences of three different treatment strategies on biochemical parameters and testicular volume (TV) in patients with idiopathic hypogonadotropic hypogonadism (IHH).

Provided treatments

  • Drug: Testosterone enanthate (Sustanon 250 mg)
  • Drug: Human chorionic gonadotropin (hCG) (Pregnyl 5000 IU)
  • Drug: Testosteron gel (Testojel 50 mg)
Tris trial is registered with FDA with number: NCT01601327. The sponsor of the trial is Gulhane School of Medicine and it is looking for 119 volunteers for the current phase.
Official trial title:
Effects of Three Different Medications on Metabolic Parameters and Testicular Volume in Patients With Hypogonadotropic Hypogonadism-Last Three Years Experience